Page last updated: 2024-09-05

deferasirox and Graft vs Host Disease

deferasirox has been researched along with Graft vs Host Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atilla, E; Demirer, T; Toprak, SK1

Reviews

1 review(s) available for deferasirox and Graft vs Host Disease

ArticleYear
Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation.
    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2017, Mar-01, Volume: 34, Issue:1

    Topics: Benzoates; Deferasirox; Ferritins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Iron Chelating Agents; Iron Overload; Survival Rate; Triazoles

2017